Loading...
RadNet, Inc.
RDNT•NASDAQ
Healthcare
Medical - Diagnostics & Research
$57.41
$1.42(2.54%)
RadNet, Inc. (RDNT) Financial Performance & Income Statement Overview
Review RadNet, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
13.18%
↑ 13.18%
Operating Income Growth
6.002%
↑ 6.002%
Net Income Growth
-8.25%
↓ 8.25%
Operating Cash Flow Growth
5.51%
↑ 5.51%
Operating Margin
6.15%
↑ 6.15%
Gross Margin
39.67%
↑ 39.67%
Net Profit Margin
1.64%
↑ 1.64%
ROE
2.60%
↑ 2.60%
ROIC
3.08%
↑ 3.08%
RadNet, Inc. (RDNT) Income Statement & Financial Overview
Review RadNet, Inc.'s (RDNT) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $477.10M | $461.14M | $459.71M | $431.71M |
| Cost of Revenue | $411.44M | $148000.00 | $424.20M | $419.96M |
| Gross Profit | $65.67M | $460.99M | $35.52M | $11.75M |
| Gross Profit Ratio | $0.14 | $1.00 | $0.08 | $0.03 |
| R&D Expenses | $0.00 | $0.00 | $3.32M | $3.31M |
| SG&A Expenses | $41.14M | $0.00 | $29.90M | $0.00 |
| Operating Expenses | $41.14M | $427.23M | $34.48M | $32.37M |
| Total Costs & Expenses | $452.58M | $427.23M | $424.20M | $419.96M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $18.07M | $19.43M | $26.08M | $16.27M |
| Depreciation & Amortization | $96.57M | $391.80M | $34.48M | $47.08M |
| EBITDA | $129.97M | $427.82M | $69.99M | $44.12M |
| EBITDA Ratio | $0.27 | $0.93 | $0.15 | $0.10 |
| Operating Income | $24.52M | $33.91M | $34.85M | $11.75M |
| Operating Income Ratio | $0.05 | $0.07 | $0.08 | $0.03 |
| Other Income/Expenses (Net) | -$9.20M | -$17.32M | -$25.45M | -$7.79M |
| Income Before Tax | $15.32M | $16.59M | $9.40M | $3.55M |
| Income Before Tax Ratio | $0.03 | $0.04 | $0.02 | $0.008 |
| Income Tax Expense | $1.10M | -$4.33M | $2.46M | -$1.86M |
| Net Income | $5.34M | $20.93M | -$2.98M | -$2.78M |
| Net Income Ratio | $0.01 | $0.05 | -$0.006 | -$0.006 |
| EPS | $0.07 | $0.28 | -$0.04 | -$0.04 |
| Diluted EPS | $0.07 | $0.28 | -$0.04 | -$0.04 |
| Weighted Avg Shares Outstanding | $73.57M | $73.49M | $73.42M | $69.31M |
| Weighted Avg Shares Outstanding (Diluted) | $75.54M | $75.17M | $73.42M | $69.31M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan